Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
22%
Ph not_applicable
3
33%
Ph early_phase_1
1
11%
Ph phase_1
1
11%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Recruiting2
Completed2
Active, not recruiting2
unknown1
Withdrawn1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 22 (28.6%)
N/A3 (42.9%)

Trials by Status

recruiting222%
unknown111%
completed222%
active_not_recruiting222%
withdrawn111%
suspended111%

Recent Activity

4 active trials
Showing 5 of 9
active_not_recruitingnot_applicable

FAZA PET/MRI Sarcoma

NCT03418818
recruiting

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

NCT04658303
recruiting

Evaluation of Hypoxia in Primary Melanoma

NCT06831071
suspendedphase_1

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer

NCT03181035
active_not_recruitingnot_applicable

Prostate Hypoxia - TIC

NCT02095249
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03418818Not Applicable

FAZA PET/MRI Sarcoma

Active Not Recruiting
NCT04658303

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Recruiting
NCT06831071

Evaluation of Hypoxia in Primary Melanoma

Recruiting
NCT03181035Phase 1

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer

Suspended
NCT02095249Not Applicable

Prostate Hypoxia - TIC

Active Not Recruiting
NCT03718650Early Phase 1

Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer

Withdrawn
NCT01992042Phase 2

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Completed
NCT02157246Not Applicable

RHYTHM-I: Investigating Hypoxia in Rectal Tumours

Completed
NCT02414048Phase 2

Hypoxia Analysis in Head and/or Neck Cancer

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9